VYLEESI: payments to doctors
Payments that named VYLEESI as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $243K
- Providers
- 4,328
- Transactions
- 5,859
- Average per transaction
- $41
The per-transaction average — $41 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,328 providers the average total is $56, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AMAG Pharmaceuticals, Inc. | $236,870 | 97.5% |
| Cosette Pharmaceuticals Inc. | $6,103 | 2.5% |